Non-invasive telemonitoring in chronic heart failure reduced all-cause mortality by 18% and heart failure hospitalisations by 20%.
Does non-invasive telemonitoring reduce mortality and hospitalizations in patients with chronic heart failure compared to standard care?
Non-invasive telemonitoring significantly reduces all-cause mortality and heart failure-specific hospitalizations in patients with chronic heart failure, with the greatest benefits observed in patients aged 70 years and older.
Absolute Event Rate: 0% vs 0%
Abstract Background Heart failure (HF) remains a leading cause of morbidity and mortality worldwide, placing a substantial burden on healthcare systems due to frequent hospitalisations and high treatment costs. Telemonitoring has emerged as a potential strategy to improve patient outcomes, yet its effectiveness remains debated. This study systematically assesses the impact of non-invasive telemonitoring on mortality and hospitalisation rates in patients with chronic HF. Purpose To evaluate the impact of non-invasive telemonitoring on all-cause mortality, HF-related hospitalizations, and overall hospitalization rates in patients with chronic heart failure, compared to standard care. Methods A systematic review and meta-analysis were conducted, including 34 randomised controlled trials (RCTs) with a total of 16,179 chronic HF patients (8,259 receiving telemonitoring and 7,920 under standard care). Data were extracted from PubMed, Excerpta Medica Database (EMBASE), and Cochrane Library until June 2023. Meta-analyses were performed using the DerSimonian and Laird random-effects model. Heterogeneity was assessed using Cochran’s Q test and the I² statistic. Risk of bias was assessed using the Risk of Bias 2 (ROB 2). Publication bias was evaluated through funnel plot asymmetry, Kendall’s correlation, and regression test. Results Non-invasive telemonitoring significantly reduced all-cause mortality by 18% (Odds Ratio OR 0.82, 95% Confidence Interval CI 0.71-0.95, p=0.007) and HF-related hospitalisations by 20% (OR 0.80, 95% CI 0.69-0.94, p=0.003). However, no significant reduction was observed in all-cause hospitalisations (OR 0.93, 95% CI 0.82-1.05, p=0.24). Subgroup analysis and linear meta-regression indicated that patients aged ≥70 years experienced greater benefits, particularly in HF-related hospitalisation reduction. Mobile-based telemonitoring demonstrated superior efficacy in reducing hospitalisations compared to other technologies. Additional benefits included improved quality of life, self-care behaviours, and treatment adherence. Conclusion Non-invasive telemonitoring is a safe and effective intervention for chronic HF management, significantly reducing mortality and HF-specific hospitalisations. Despite these benefits, further research is required to assess cost-effectiveness, long-term patient adherence, and integration into routine clinical practice. This study presents original data and findings without referencing specific institutions, cities, or countries, in accordance with ESC submission guidelines.
Parente et al. (Sat,) reported a other. Non-invasive telemonitoring in chronic heart failure reduced all-cause mortality by 18% and heart failure hospitalisations by 20%.